🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
The objectives of this study are to evaluate the safety and efficacy of Via...
Status
Completed
Location
Arkansas Children's Hospital
Start Date
2014-11
Trial ID
NCT02223182
Treatments Being Tested
This study aims at showing that Epicutaneous Immunotherapy with peanut prot...
Status
Completed
Location
Hopital Necker
Start Date
2010-08
Trial ID
NCT01197053
Treatments Being Tested
The study aims to assess the safety and efficacy of Viaskin Peanut to induc...
Status
Completed
Location
University of Arizona Health Science
Start Date
2017-07-31
Trial ID
NCT03211247
Evaluation of patch as specific immunotherapy in allergic patients...
Status
Completed
Location
Multiple Locations
Start Date
2008-02
Trial ID
NCT00719511
The purpose of this phase 1b study is to evaluate the safety and tolerabili...
Status
Completed
Location
Arkansas Children's Hospital
Start Date
2010-07
Trial ID
NCT01170286
Treatments Being Tested
The EVE-PMS technology is intended for determination of intolerance or sens...
Status
Unknown
Location
Sheba Medical Center, Tel-Hashomer
Start Date
2009-04
Trial ID
NCT00866437
Treatments Being Tested
The EVE- technology is intended for determination of intolerance or sensiti...
Status
Unknown
Location
Depts. Gynecology and Obstetrics and 3rd Dept of Internal Medicine
Start Date
2010-06
Trial ID
NCT01175759
Treatments Being Tested
Open-label, follow-up study for subjects who completed the EPITOPE study....
Status
Completed
Location
Banner University Medical Center Tucson
Start Date
2018-12-06
Trial ID
NCT03859700
Treatments Being Tested
This is a single-site, double-blind, placebo-controlled, randomized trial t...
Status
Completed
Location
The Children's Hospital of Philadelphia
Start Date
2015-10
Trial ID
NCT02579876
Treatments Being Tested
The primary objective of this study is to assess the 6-month safety of DBV7...
Status
Active Not Recruiting
Location
AllerVie Clinical Research
Start Date
2025-06-24
Trial ID
NCT07003919
Treatments Being Tested